Samsung Medical Center
Kidney cancer treatment cost in the Republic of Korea typically begins with essential screening such as a PET/CT scan, which costs $1,000 to $1,500. Primary surgical interventions like a nephrectomy run from $9,000 to $14,500, while a laparoscopic nephrectomy ranges from $14,200 to $17,300. Total expenses depend on the surgical approach, hospital tier, and the patient's insurance status. Patients can expect 30-50% savings compared to the US. Most specialized centers are located in Seoul and Incheon.
Typical Kidney Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking the most advanced surgical precision should consider robotic-assisted options. Seoul St. Mary's Hospital offers robotic surgery packages starting around $20,000. These include a 7-day hospital stay and care from specialists like Dr. Hong Sung Hoo. For complex cases, JCI-accredited centers like Severance Hospital or Samsung Medical Center provide multidisciplinary teams. These facilities are ideal for patients requiring integrated oncology and urology expertise.
| Republic of Korea | Turkey | Austria | |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Nephrectomy with Da Vinci Robot | from $16,000 | from $10,000 | from $16,000 |
| Nephrectomy | from $9,000 | from $10,000 | from $22,000 |
| NanoKnife | from $17,500 | from $9,500 | from $25,000 |
| Laparoscopic nephrectomy | from $14,200 | from $12,830 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Kidney cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Kidney cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Kidney cancer treatment journey.
Head of Urology at Samsung Medical Center – Dr. Choi specializes in kidney cancer surgery with a focus on precision and patient outcomes.
Dr. Won Sik Ham is a urologist and oncosurgeon at Severance Hospital, specializing in cancer surgeries.
Specialist in laparoscopic and robotic surgeries for kidney cancer at Severance Hospital.
Dr. Seong Soo Jeon is the Head of the Urology Department at Samsung Medical Center. He specializes in the treatment of prostate, kidney, and bladder cancer. Dr. Jeon uses robotic and laparoscopic techniques to preserve potency and urinary function. He earned his medical degree from Seoul National University.
South Korea prioritizes minimally invasive surgery for kidney cancer, with over 80% of cases involving surgical intervention. Leading Seoul hospitals combine robotic Da Vinci systems, immunotherapy, and targeted drugs to treat advanced stages. These JCI-accredited centers specialize in nephrectomy and ablation to preserve renal function.
Bookimed Expert Insight: South Korea leads in digital health integration. Hospitals like Seoul National University Bundang Hospital and Samsung Medical Center use digital systems to eliminate medical errors. This is critical for kidney cancer, where precise staging via PET/CT determines if a patient can undergo a partial nephrectomy instead of total removal. This high-tech approach supports the 90% success rate seen in complex procedures at top-ranked facilities.
Patient Consensus: Patients often recommend robotic partial nephrectomy for a recovery time of 2 to 4 weeks. They emphasize getting a second opinion to see if a kidney-sparing surgery is possible.
Robotic surgery is a leading treatment for kidney cancer in South Korea. Specialized centers frequently use the da Vinci system for partial nephrectomies to preserve renal function. It now surpasses traditional methods in volume at major Seoul institutions like Samsung Medical Center and Asan Medical Center.
Bookimed Expert Insight: Korea University Anam Hospital offers a distinct advantage for patients requiring complex reconstructions. They developed the world’s first robotic oral thyroid surgery and apply similar expertise to bladder-preservation robotic protocols. This specialized experience suggests their surgeons handle high-precision reconstruction better than centers focused only on tumor removal.
Patient Consensus: Patients note that robotic precision is a major draw at centers like Asan, though it may not be standard for every case. They emphasize verifying a surgeon's specific robotic volume to ensure a smooth procedure without switching to open surgery.
South Korea provides broad access to the latest immunotherapy drugs. National health insurance covers major therapies like pembrolizumab and durvalumab. Recent expansions in 2026 significantly increased the number of covered indications. Patients with approved conditions typically pay only 5% of drug costs.
Bookimed Expert Insight: While South Korea ranks 8th globally for medical requests on our platform, patients often overlook the reimbursement gap. Large institutions like Severance Hospital and Asan Medical Center frequently run clinical trials for drugs not yet fully covered by insurance. This provides early access to new combinations before they reach the national reimbursement list.
Patient Consensus: Patients recommend using the HIRA mobile app to check drug coverage status before traveling. Many suggest looking into compassionate access programs if a specific newer combination remains waitlisted for insurance coverage.
Top hospitals for international kidney cancer patients include Samsung Medical Center and Asan Medical Center. These facilities hold Newsweek rankings and JCI or KOIHA accreditations. They offer advanced robotic-assisted partial nephrectomy and proton-beam therapy. Patients benefit from short wait times of 1 to 2 weeks.
Bookimed Expert Insight: Samsung Medical Center and Seoul National University Hospital stand out because they treat the Republic of Korea's president. This signals the highest possible trust in their clinical outcomes. While both are prestigious, our data shows Korea University Anam Hospital performed Asia's first pre-stage robotic bladder surgery. This indicates a very high level of robotic proficiency that extends to complex kidney cases.
Patient Consensus: Patients note that South Korean hospitals offer much faster access to surgery than Western centers. They emphasize the importance of using dedicated international clinics to manage visas and English communication effectively.
South Korea reports a 5-year relative survival rate of 83.1% for kidney cancer. This surpasses the 68.6% average survival rate across Asia. For localized cases, the survival rate reaches 98.1%. These outcomes match or exceed standards in the United States and Europe.
Bookimed Expert Insight: South Korea offers a significant advantage in surgical speed compared to North American and European systems. While many Western patients wait 3 to 6 months for surgery, Korean centers like Samsung Medical Center or Severance often schedule procedures within weeks. This rapid intervention is critical for kidney cancer, as early surgery directly correlates with the 98.1% success rate found in localized cases.
Patient Consensus: Patients note that while success rates mirror the high standards of the US, the speed of access in Seoul is a deciding factor. They emphasize arranging a translator early to navigate the hospital experience effectively.
Patients should plan for a 7 to 14 day stay in South Korea for kidney cancer treatment. This period accounts for pre-operative tests and post-surgical recovery. Most hospitalizations last between 2 and 7 days. Total recovery time depends on the surgical method used.
Bookimed Expert Insight: South Korean oncology centers like Samsung Medical Center and Asan Medical Center manage exceptionally high patient volumes. Asan Medical Center alone performs over 65,000 operations annually. This high frequency often leads to standardized, efficient discharge protocols where patients leave the hospital faster than in the US.
Patient Consensus: Patients recommend booking flexible flights and local housing for at least 3 weeks. They emphasize confirming if pathology reports can be emailed to avoid waiting in Seoul for results.
To find a qualified kidney cancer surgeon in South Korea, identify board-certified urologists at JCI-accredited facilities like Severance Hospital or Samsung Medical Center. Focus on clinicians specializing in robotic-assisted Da Vinci nephrectomy and laparoscopic procedures. These centers handle high volumes of complex oncology cases annually.
Bookimed Expert Insight: South Korea's top oncology centers demonstrate high levels of specialization through patient-to-department ratios. For example, Korea University Anam Hospital maintains over 40 distinct departments while serving 1.3 million patients annually. This scale allows surgeons like Dr. Kang Seok-ho to focus almost exclusively on robotic urological procedures. Such narrow specialization typically results in higher surgical precision and better outcomes for kidney-sparing treatments.
Patient Consensus: Patients emphasize choosing high-volume centers like Samsung or Asan for their established English-speaking support. Many suggest obtaining a second opinion from Severance Hospital specialists to compare specific robotic surgery plans before proceeding.
South Korea reports an 83.1% five-year survival rate for kidney cancer. Leading Seoul institutions use robotic-assisted Da Vinci systems and proton-beam therapy to achieve these outcomes. Specialists like Dr Choi Han Yong at Samsung Medical Center focus on precision surgery to improve patient results.
Bookimed Expert Insight: South Korea's high success rates stem from hospital digitalisation and high surgical volume. Seoul National University Bundang Hospital became the first digital hospital using the BESTcare system. This technology reduces medical errors. It helps explain why Korean centres outpace many global benchmarks.
Patient Consensus: Patients note that Korean hospitals provide fast diagnostic work-ups and highly organised care. They suggest asking for stage-specific survival figures rather than general country averages when planning treatment.
Surgical options for kidney cancer in South Korea focus on minimally invasive techniques for organ preservation. Surgeons perform robotic partial nephrectomy, laparoscopic removal, and radical surgery. Centres in Seoul use the Da Vinci system to excise tumours while saving healthy kidney tissue.
Bookimed Expert Insight: Korea's infrastructure is built for high-volume precision. Seoul National University Bundang Hospital was the first fully digital hospital. This digital integration reduces medical errors. Centres like Samsung Medical Center handle over 45,000 operations annually. This immense volume allows urologists like Dr Choi Han Yong to refine protocols. These protocols prioritise preserving renal function in complex cases.
Immunotherapy and immune checkpoint inhibitors for kidney cancer are available in the Republic of Korea. JCI-accredited facilities like Severance Hospital and Samsung Medical Center offer these treatments for renal cell carcinoma. Multidisciplinary teams manage complex cases using modern oncology protocols.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually. It holds a special hospital of presidential standards status. This massive patient volume means their oncologists handle rare kidney cancer subtypes frequently. For complex or metastatic cases, this high-volume expertise often leads to refined immunotherapy dosing strategies.
Patient Consensus: Patients should confirm if clinics offer immunotherapy for metastatic disease before travelling to South Korea. They suggest verifying that the hospital coordinates pathology reviews and monitors for potential infusion side effects.
The Republic of Korea offers high-standard kidney cancer care through robotic technology and JCI-accredited facilities. Specialists prioritise nephron-sparing surgeries like partial nephrectomy to preserve kidney function. Leading Seoul clinics maintain international quality standards through KOIHA and ISO certifications. They also provide rapid access to intensive targeted therapies.
Bookimed Expert Insight: Korean oncology outcomes benefit from a high concentration of surgical volume in Seoul. Asan Medical Center treats over 182,000 patients. Seoul National University Hospital is digitalised for efficiency. This high patient turnover means surgeons like Dr Koon Ho Rha handle more complex urological cases than most international peers.